Cardiovascular complications secondary to Graves' disease: a prospective study from Ukraine

Graves' disease (GD) is a common cause of hyperthyroidism resulting in development of thyrotoxic heart disease (THD). to assess cardiovascular disorders and health related quality of life (HRQoL) in patients with THD secondary to GD. All patients diagnosed with THD secondary to GD between Janua...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:PloS one 2015-03, Vol.10 (3), p.e0122388-e0122388
Hauptverfasser: Tsymbaliuk, Iryna, Unukovych, Dmytro, Shvets, Nataliia, Dinets, Andrii
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Graves' disease (GD) is a common cause of hyperthyroidism resulting in development of thyrotoxic heart disease (THD). to assess cardiovascular disorders and health related quality of life (HRQoL) in patients with THD secondary to GD. All patients diagnosed with THD secondary to GD between January 2011 and December 2013 were eligible for this study. Clinical assessment was performed at baseline and at the follow-up visit after the restoring of euthyroid state. HRQoL was studied with a questionnaire EQ-5D-5L. Follow-up data were available for 61 patients, but only 30 patients with THD secondary to GD were consented to participate in investigation of their HRQoL. The frequency of cardiovascular complications was significantly reduced as compared before and after the antithyroid therapy as follows: resting heart rate (122 vs. 74 bpm), blood pressure: systolic (155 vs. 123 mm Hg), diastolic (83 vs. 66 mm Hg), supraventricular premature contractions (71% vs. 7%), atrial fibrillation (72% vs. 25%), congestive heart failure (69% vs. 20%), thyrotoxic cardiomyopathy (77% vs. 26%), all p
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0122388